NCT00551876View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

214

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

MK0653, ezetimibe / Duration of Treatment: 30 Weeks

DRUG

Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00551876 - Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED) | Biotech Hunter | Biotech Hunter